Terranueva Closes a Private Placement of $1,050,000
L’ASSOMPTION, Québec, March 22, 2021 (GLOBE NEWSWIRE) -- TERRANUEVA CORPORATION (CSE : TEQ) (“Terranueva” or the “Corporation”) is pleased to announce the...
News
Rezolute Presents Data on RZ358 in Post-Gastric Bypass Hypoglycemia at ENDO 2021
REDWOOD CITY, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “the Company”) (Nasdaq: RZLT) today presented positive...
The Augustinians Fathers and Mariann Home announce expansion and relocation of long-term care facility to the Marylake Campus in King Township
KING TOWNSHIP, Ontario, March 22, 2021 (GLOBE NEWSWIRE) -- The Marylake Augustinian Fathers in King City and the Midwest Augustinian...
Decibel Therapeutics Added to Russell 2000 Index
BOSTON, March 22, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX) (“Decibel”), a clinical-stage biotechnology company dedicated to discovering and...
BioCryst’s Oral Factor D Inhibitor, BCX9930, Advancing to Pivotal Trials in PNH Following Successful Proof of Concept Trial
—Following doses of 400 mg bid or 500 mg bid of oral BCX9930, 100 percent of treatment-naïve patients and 83...
Sensei Biotherapeutics Announces Inclusion in Russell 2000 Index
BOSTON and ROCKVILLE, Md., March 22, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage immunotherapy company focused...
Context Therapeutics® Expands Board of Directors
-- Company Adds Richard Berman, Jennifer Evans Stacey and Linda West to Board -- -- Appointments Bolster Business and Clinical...
Shockwave Announces Joint Venture in China
Establishes a Company to Maximize the Availability of IVL for the Chinese PopulationSANTA CLARA, Calif., March 22, 2021 (GLOBE NEWSWIRE)...
RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dermatitis
Company Reaffirms Guidance to Report Data in 1H 2021SOUTH SAN FRANCISCO, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics,...
Daré Bioscience Completes Recruitment in Phase 1 Clinical Trial of DARE-HRT1, a Novel Intravaginal Ring Designed to Deliver Non-Oral, Bio-identical Hormone Therapy for the Treatment of Vasomotor Symptoms and Genitourinary Syndrome Associated with Menopause
Topline data readout anticipated in the second quarter 2021SAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader...
Humana Expands Use of the Inovalon ONE® Platform
Leading National Health Plan to Implement Vaccine Adherence ProgramBOWIE, Md., March 22, 2021 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider...
Terns Announces Initiation of Dosing in Phase 1 Clinical Trial of TERN-501, its THR-Beta Agonist in Development for the Treatment of NASH
-TERN-501 is designed to have high metabolic stability, enhanced liver distribution and high selectivity for THR-β- -Top-line data expected in...
InspireMD CEO Marvin Slosman Issues Letter to Fellow Stockholders Urging Support of the Company’s Plans to List its Common Stock on Nasdaq at the Upcoming Special Meeting of Stockholders
TEL AVIV, Israel, March 22, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention...
XOMA Announces Approval of First Preferred Stock Dividend
EMERYVILLE, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board...
Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer
CEO appointment provides continuity and reflects company’s demonstrated strong operational performanceNEW YORK and CLEVELAND, March 22, 2021 (GLOBE NEWSWIRE) --...
Translate Bio Appoints Dr. Rand Sutherland as President
-- 20 years of combined industry, medical and academic expertise in pulmonary and rare disease to support continued advancement of...
Cybrexa Therapeutics Receives Green Light from FDA on Investigational New Drug Application for CBX-12 (alphalex™-exatecan)
Cybrexa plans to initiate Phase I clinical trial in April 2021NEW HAVEN, Conn., March 22, 2021 (GLOBE NEWSWIRE) -- Cybrexa...
Crinetics Pharmaceuticals Pipeline Progress on Display at ENDO 2021
Oral and Late-breaker Presentations Selected on the Company’s ACTH Antagonist and Congenital HI ProgramsSAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE)...
Cerevel Therapeutics to Present at the Stifel 3rd Annual CNS Day Event
CAMBRIDGE, Mass., March 22, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of...
AzurRx BioPharma Announces Completion of Enrollment in Phase 2 Clinical Trial of MS1819 in Combination with PERT in the Treatment of Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency
Top-line data expected in Q2 2021DELRAY BEACH, Fla., March 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx”...